Literature DB >> 19211895

Neuroimaging and physiological evidence for involvement of glutamatergic transmission in regulation of the striatal dopaminergic system.

Masaki Tokunaga1, Nicholas Seneca, Ryong-Moon Shin, Jun Maeda, Shigeru Obayashi, Takashi Okauchi, Yuji Nagai, Ming-Rong Zhang, Ryuji Nakao, Hiroshi Ito, Robert B Innis, Christer Halldin, Kazutoshi Suzuki, Makoto Higuchi, Tetsuya Suhara.   

Abstract

Aberrant neurotransmissions via glutamate and dopamine receptors have been the focus of biomedical research on the molecular basis of psychiatric disorders, but the mode of their interaction is yet to be uncovered. In this study, we demonstrated the pharmacological reversal of methamphetamine-stimulated dopaminergic overflow by suppression of group I metabotropic glutamate (mGlu) receptor in living primates and rodents. In vivo positron emission tomography (PET) was conducted on cynomolgus monkeys and rats using a full agonistic tracer for dopamine D(2/3) receptor, [(11)C]MNPA [(R)-2-(11)CH(3)O-N-n-propylnorapomorphine], and fluctuation of kinetic data resulting from anesthesia was avoided by scanning awake subjects. Excessive release of dopamine induced by methamphetamine and abolishment of this alteration by treatment with an antagonist of group I mGlu receptors, 2-methyl-6-(phenylethynyl)pyridine (MPEP), were measured in both species as decreased binding potential because of increased dopamine and its recovery to baseline levels, respectively. Counteraction of MPEP to the methamphetamine-induced dopamine spillover was also supported neurochemically by microdialysis of unanesthetized rat striatum. Moreover, patch-clamp electrophysiological assays using acute brain slices prepared from rats indicated that direct targets of MPEP mechanistically involved in the effects of methamphetamine are present locally within the striatum. Because MPEP alone did not markedly alter the baseline dopaminergic neurotransmission according to our PET and electrophysiological data, the present findings collectively extend the insights on dopamine-glutamate cross talk from extrastriatal localization of responsible mGlu receptors to intrastriatal synergy and support therapeutic interventions in case of disordered striatal dopaminergic status using group I mGlu receptor antagonists assessable by in vivo imaging techniques.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211895      PMCID: PMC2746446          DOI: 10.1523/JNEUROSCI.2559-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  65 in total

1.  Dopaminergic modulation of excitatory postsynaptic currents in rat neostriatal neurons.

Authors:  M Umemiya; L A Raymond
Journal:  J Neurophysiol       Date:  1997-09       Impact factor: 2.714

Review 2.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

3.  Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.

Authors:  Nicholas Seneca; Sjoerd J Finnema; Lars Farde; Balázs Gulyás; Håkan V Wikström; Christer Halldin; Robert B Innis
Journal:  Synapse       Date:  2006-04       Impact factor: 2.562

4.  Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.

Authors:  B Moghaddam; B W Adams
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

5.  Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes.

Authors:  G Page; M Peeters; M Najimi; J M Maloteaux; E Hermans
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

6.  Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.

Authors:  Bart N M van Berckel; Lawrence S Kegeles; Rikki Waterhouse; Ningning Guo; Dah-Ren Hwang; Yiyun Huang; Rajesh Narendran; Ronald Van Heertum; Marc Laruelle
Journal:  Neuropsychopharmacology       Date:  2006-05       Impact factor: 7.853

7.  Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.

Authors:  M Scarponi; G Bernardi; N B Mercuri
Journal:  Eur J Neurosci       Date:  1999-02       Impact factor: 3.386

8.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

9.  Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.

Authors:  Paul Cumming; Dean F Wong; Nicholas Gillings; John Hilton; Ursula Scheffel; Albert Gjedde
Journal:  J Cereb Blood Flow Metab       Date:  2002-05       Impact factor: 6.200

10.  Dopamine D2 receptor binding sites for agonists. A tetrahedral model.

Authors:  P Seeman; M Watanabe; D Grigoriadis; J L Tedesco; S R George; U Svensson; J L Nilsson; J L Neumeyer
Journal:  Mol Pharmacol       Date:  1985-11       Impact factor: 4.436

View more
  11 in total

1.  Measurement error analysis for the determination of dopamine D(2) receptor occupancy using the agonist radioligand [(11)C]MNPA.

Authors:  Miho Shidahara; Hiroshi Ito; Tatsui Otsuka; Yoko Ikoma; Ryosuke Arakawa; Fumitoshi Kodaka; Chie Seki; Harumasa Takano; Hidehiko Takahashi; Federico E Turkheimer; Yuichi Kimura; Iwao Kanno; Tetsuya Suhara
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-16       Impact factor: 6.200

2.  Nonhuman primate positron emission tomography neuroimaging in drug abuse research.

Authors:  Leonard Lee Howell; Kevin Sean Murnane
Journal:  J Pharmacol Exp Ther       Date:  2011-02-11       Impact factor: 4.030

3.  Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice.

Authors:  Francesca Managò; Sebastien Lopez; Alberto Oliverio; Marianne Amalric; Andrea Mele; Elvira De Leonibus
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

4.  Antagonism of metabotropic glutamate 1 receptors attenuates behavioral effects of cocaine and methamphetamine in squirrel monkeys.

Authors:  Cindy Achat-Mendes; Donna M Platt; Roger D Spealman
Journal:  J Pharmacol Exp Ther       Date:  2012-07-18       Impact factor: 4.030

5.  Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men.

Authors:  Moupali Das; Deirdre Santos; Tim Matheson; Glenn-Milo Santos; Priscilla Chu; Eric Vittinghoff; Steve Shoptaw; Grant N Colfax
Journal:  AIDS       Date:  2010-04-24       Impact factor: 4.177

Review 6.  Neuroimaging and drug taking in primates.

Authors:  Kevin S Murnane; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2011-03-01       Impact factor: 4.530

7.  Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) Mice.

Authors:  Jongho Kim; Andrew G Horti; William B Mathews; Vladimir Pogorelov; Heather Valentine; James R Brasic; Daniel P Holt; Hayden T Ravert; Robert F Dannals; Luewi Zhou; Bruno Jedynak; Atsushi Kamiya; Mikhail V Pletnikov; Dean F Wong
Journal:  Mol Imaging Biol       Date:  2015-06       Impact factor: 3.488

8.  Impact of isoflurane anesthesia on D2 receptor occupancy by [18F]fallypride measured by microPET with a modified Logan plot.

Authors:  Mohammed N Tantawy; Todd E Peterson; Carrie K Jones; Kari Johnson; Jerri M Rook; P Jeffrey Conn; Ronald M Baldwin; M Sib Ansari; Robert M Kessler
Journal:  Synapse       Date:  2011-06-17       Impact factor: 2.562

9.  Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.

Authors:  Masafumi Shimojo; Hiroyuki Takuwa; Yuhei Takado; Masaki Tokunaga; Satoshi Tsukamoto; Keiichiro Minatohara; Maiko Ono; Chie Seki; Jun Maeda; Takuya Urushihata; Takeharu Minamihisamatsu; Ichio Aoki; Kazunori Kawamura; Ming-Rong Zhang; Tetsuya Suhara; Naruhiko Sahara; Makoto Higuchi
Journal:  J Neurosci       Date:  2020-04-07       Impact factor: 6.167

10.  Mephedrone and nicotine: oxidative stress and behavioral interactions in animal models.

Authors:  Barbara Budzynska; Anna Boguszewska-Czubara; Marta Kruk-Slomka; Jacek Kurzepa; Grazyna Biala
Journal:  Neurochem Res       Date:  2015-04-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.